WebJun 10, 2024 · Epstein–Barr virus (EBV)-associated NK/T-cell lymphoproliferative disorder (LPD) involving the gastrointestinal tract is rarely observed in individuals with normal immunity. The atypical clinical, colonoscopic manifestations often confuse clinicians, leading to misdiagnosis and delays in the treatment. Herein, we reported on a single … WebJan 1, 2000 · In Section III, Dr. Gross reviews the treatment of EBV-associated lymphoproliferative disorders in primary immunodeficiencies and in post-transplant patients. He gives an update on the recent molecular discoveries in X-linked lymphoproliferative disorder. Preliminary results of a phase II trial of low-dose …
Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
WebThe Epstein–Barr virus (EBV), formally called Human gammaherpesvirus 4, is one of the nine known human herpesvirus types in the herpes family, and is one of the most common viruses in humans. EBV is a double-stranded DNA virus.. The virus causes infectious mononucleosis ("mono" or "glandular fever"). It is also associated with various non … WebApr 14, 2024 · Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: ... Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Exp Mol Med 2015;47:e136. DOI PubMed PMC; 73. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-21. DOI … richard movsessian
Virological markers in epstein-barr virus-associated diseases
WebFeb 4, 2024 · Most infected people are asymptomatic and do not show serious sequelae, while others may develop Epstein-Barr virus (EBV)-positive T and NK-cell lymphoproliferations characterised by EBV-infected T or NK cells. These disorders are more common in Asian and Latin American people, suggesting genetic predisposition as … WebJan 14, 2024 · A related article has been published: Collins PJ, Fox CP, George L, et al. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid … WebFeb 22, 2024 · Epstein-Barr virus (EBV) infection may present or evolve during the acute phase to a fulminant disease manifesting with severe constitutional symptoms, systemic lymphadenopathy, and associated cytopenia(s). In such clinical scenarios, tissue biopsy may be performed to exclude an underlying lymphoproliferative disorder. richard mowat